BITGF:OTC-Biotage AB (publ) (USD)

COMMON STOCK | | OTC

Last Closing Price

USD 29.44

Change

0.00 (0.00)%

Market Cap

USD 0.77B

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

Biotage AB (publ) (BITGF) Stock Analysis:
Based on the Biotage AB (publ) stock forecasts from 1 analysts, the average analyst target price for Biotage AB (publ) is USD 0.00 over the next 12 months. Biotage AB (publ)’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Biotage AB (publ) is Slightly Bullish , which is based on 2 positive signals and 1 negative signals. At the last closing, Biotage AB (publ)’s stock price was USD 29.44. Biotage AB (publ)’s stock price has changed by +0.00 % over the past week, +4.54 % over the past month and +59.11 % over the last year.

About

Biotage AB (publ), a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. It offers sample preparation solution ...Read More

Employees : 438

Currency: USD

Country : USA

Technical Indicators

Beta : 0.85

52 Week High : 14.40

52 Week Low : 11.75

200 Day Moving Average : 12.89

50 Day Moving Average : 11.75

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-02 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BTHI Big Time Holdings, Inc

N/A

 USD151.65B N/A N/A
ERGN Ergo Science Corporation

N/A

 USD55.23B N/A N/A
WOLTF Wolters Kluwer N.V

N/A

 USD30.84B 37.61 N/A
STMZF Scottish Mortgage Investment T..

-0.39 (-1.99%)

 USD29.99B 3.82 N/A
MRVGF Mirvac Group

N/A

 USD24.50B 11.68 24.47
FYRTF FamilyMart Co., Ltd

N/A

 USD24.28B 60.20 N/A
EPOKF Epiroc AB (publ)

N/A

 USD23.71B 19.70 N/A
ETTYF Essity AB (publ)

N/A

 USD22.58B 26.92 N/A
ZLDSF Zalando SE

N/A

 USD22.24B 74.20 N/A
EPKAF Epiroc AB (publ)

N/A

 USD20.70B 18.20 N/A

ETFs Containing BITGF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification ()		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 83.97% N/A N/A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.97% N/A N/A 83% B
Trailing 12 Months  
Capital Gain 59.11% N/A N/A 76% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.11% N/A N/A 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 24.72% N/A N/A 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.72% N/A N/A 59% F
Risk Return Profile  
Volatility (Standard Deviation) 26.25% N/A N/A 72% C-
Risk Adjusted Return 94.17% N/A N/A 97% A+
Market Capitalization 0.77B N/A N/A 64% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
()		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 40.60 N/A N/A 17% F
Price/Book Ratio 12.69 N/A N/A 11% F
Price / Cash Flow Ratio 5.00 N/A N/A 27% F
EV/EBITDA 280.89 N/A N/A 2% F
Management Effectiveness  
Return on Equity 24.47% N/A N/A 89% B+
Return on Invested Capital 21.45% N/A N/A 84% B
Return on Assets 10.60% N/A N/A 93% A
Debt to Equity Ratio 15.58% N/A N/A 61% D-
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.85 N/A N/A 50% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.